Table 3.
Measure | Full Sample (N=635) |
Patients With Anxiety Disorders (N=48) |
Patients Without Anxiety Disorders (N=587) |
Unadjusted Analyses |
Adjusted Analyses |
||
---|---|---|---|---|---|---|---|
N (%) | N (%) | N (%) | O.R. | p-value | O.R. | p-value | |
Treatment with anxiolytics | 36 (5.70) | 5 (10.4) | 31 (5.10) | 2.07 | 0.15 | 1.44 | 0.53 |
Terminal Illness Acknowledgement | 204 (34.6) | 19 (42.2) | 185 (33.9) | 1.42 | 0.26 | 1.27 | 0.49 |
Treatment Preferences | |||||||
Preference for chemotherapy | 327 (52.6) | 27 (56.3) | 300 (52.3) | 1.17 | 0.60 | 1.18 | 0.61 |
Preference for antibiotics | 287 (46.9) | 23 (47.9) | 264 (46.8) | 1.05 | 0.88 | 0.96 | 0.89 |
Preference for feeding tube | 216 (36.1) | 22 (50.0) | 194 (35.0) | 1.86 | 0.05 | 1.58 | 0.18 |
Preference for respirator | 160 (25.6) | 16 (33.3) | 144 (25.0) | 1.50 | 0.21 | 1.34 | 0.40 |
Preference for any type of advanced treatment |
448 (71.0) | 34 (70.8) | 414 (71.0) | 0.99 | 0.98 | 0.91 | 0.78 |
Extend Life Versus Relieve Pain | 165 (28.8) | 17 (40.5) | 148 (27.8) | 1.77 | 0.08 | 1.57 | 0.21 |
Heroic Measures | 129 (20.8) | 9 (18.8) | 120 (21.0) | 0.87 | 0.71 | 0.62 | 0.26 |
Advance Care Planning | |||||||
DNR | 242 (38.8) | 17 (35.4) | 225 (39.1) | 0.86 | 0.62 | 0.78 | 0.45 |
Living will | 335 (53.9) | 22 (45.8) | 313 (54.5) | 0.71 | 0.25 | 0.85 | 0.62 |
Health Care Proxy and/or Durable Power of Attorney |
339 (54.5) | 24 (50.0) | 315 (54.9) | 0.82 | 0.52 | 0.96 | 0.90 |
Note: Bolded p-values represent significant differences between patients with and without anxiety disorders.
Adjusted Analyses control for age, gender and karnofsky performance score; Missing Data: Anxiolytics (3), Terminal Illness Acknowledgement (45), Chemotherapy Preference (13), Antibiotics Preference (23), Feeding Tube Preference (37), Respirator Preference (11), Any Aggressive Preference (74), Life Extension (61), Heroic Measures (16), DNR (11), Living Will (13), Health Care Proxy (13)